CCNDBP1 and neoplasm: Univariate analysis indicated that with the AOD value of 0.1950 as the boundary, the low CCNDBP1 protein expression level (P = 0.0016, Figure 3A), clinical-stage IV (P < 0.0001, Figure 3B), and tumor site (P = 0.0194, Figure 3C) were correlated with the short PFS of the patients.